期刊文献+

低分子肝素对下肢深静脉血栓的应用 被引量:3

Given Low melecular heparins to cure deep venous thrombosisia
下载PDF
导出
摘要 目的 探索低分子肝素对DVT的治疗效果。方法 下肢深静脉血栓患者32例,应用低分子肝素治疗深静脉血栓形成,观察疗效。结果 32例下肢深静脉血栓形成的患者治愈8例,占25.00%,显效14例,占43.75%,有效8例,占25.00%,无效2例,占6.25%。结论 应用低分子肝素是治疗下肢深静脉血栓的有效、安全和简便的方法。 Objective To study the clinical effection of low melecular heparins to cure Deep venous thrombosisia. Methods Given low melecular heparins to cure Deep venous thrombosisia, and to investigate the effection, Rusults 32 cases of deep venous thrombosisia, 8 cases recovered, 25%, 14 cases significant effective, 43.75%, 8 cases effective, 25%, 2 cases invalid, 6.25%. conclusion Use low melecular heparins to cure deep venous thrombosisia is the methods of afficacy, safety and easy.
出处 《国际医药卫生导报》 2003年第16期10-11,共2页 International Medicine and Health Guidance News
关键词 低分子肝素 下肢深静脉血栓 DVT LMWH Low melecular heparins Deep venous thrombosis
  • 相关文献

参考文献3

  • 1[1]Cosmi b, Hirsh j. Low Molecular weight heparins. Current Opinion in Cardiology, 1994,9:612-618
  • 2[2]Leizorovicz A, Simonneau G, decousus H, et al. Compairson of afficacy and safety of low molecular weight heparins and unfractionated heparin ininitial treament of deep venous thrombosis:a meta-anaiysis. Br Med j,1994,309:299-304
  • 3[3]Anthonie W, Marrin H, Bruce L, et al. Treatment of deep venous thrombosis with low molecular weight heparins.Arch intern Med, 1995,155,:601-607

同被引文献12

  • 1范晓东,金松,秦德军,王跃生.巴曲酶治疗下肢深静脉血栓形成临床分析[J].黑龙江医药科学,2007,30(4):50-50. 被引量:1
  • 2White H, Hirulog and Early Reperfiasion or Occlusion(HERO)-2 Trial Investigators.Thrombin-specific anticoagu—lation with bivalirudin versus heparin in patients receivingfibrinolytic therapy for acute myocardial infarction: theHERO-2 randomised trial [J].Lancet,2001,358 (9296):1855-1863.
  • 3Anand SX,Kim MC,Kamran M,et al. Comparison of plateletfunction and morphology in patients undergoing percutaneouscoronary intervention receiving bivalirudin versus unfrac-tionated heparin versus clopidogrel pretreatment and hi-valirudin[J]. Am J Cardiol,2007,100(3):417-424.
  • 4Pratic 6 D,Pasin M,Barry OP,et al.Iron-dependent humanplatelet activation and hydroxyl radical formation : involve-ment of protein kinase C [J].Circulation, 1999,99 (22):3118-3124.
  • 5Kurz KD, Main BW,Sandusky GE. Rat model of arterialthrombosis induced by ferric chloride [JJ.Thromb Res,1990,60(4):269-280.
  • 6Toka M, Ozeren A, Aktan M,et al.The role of inflammationmarkers in triggering acute conr-onary events [J]. HeartVessels,2003,18(4) :171-176.
  • 7Anrlr e P,Hartwell D,Hrachovinov a I,et al. Pro—coagulantstate resulting from high levels of soluble P-selectin in blood[J], Proc Natl Acad Sci USA,2000,97(25): 13835-13840.
  • 8Vance GN, Brad L, William QC,et al. Argatrohan, Bi-valirudin, and Lepimdin do not Decrease Clot Propagationand Strength as Effectively as Heparin-activated Antithrom-hin In Vitro [J]. The Journal of Hear Lung Transplantation,2006,189(6):653-662.
  • 9Schneider DJ, Keating F,Sobel BE.Greater inhibitory effectsof bivalirudin compared with unfractionated heparin plus ep-tifibitide on thrombin-induced platelet activation[J].CoronaryArtery Disease,2006,17(5) :471-476.
  • 10Schneider DJ,Keating F, Sobel BE.Greater inhibitory effectsof bivalirudin compared with unfractionated heparin plus ep—tifibitide on thrombin-induced platelet activation[J]. CoronaryArtery Disease,2006,121(7):471-476.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部